On Monday, Aldeyra Therapeutics Inc (NASDAQ: ALDX) opened higher 11.69% from the last session, before settling in for the closing price of $4.96. Price fluctuations for ALDX have ranged from $1.14 to $7.20 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 15.99% annually for the last half of the decade. Company’s average yearly earnings per share was noted 34.31% at the time writing. With a float of $58.21 million, this company’s outstanding shares have now reached $60.16 million.
Aldeyra Therapeutics Inc (ALDX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Aldeyra Therapeutics Inc is 3.24%, while institutional ownership is 65.69%. The most recent insider transaction that took place on Aug 13 ’25, was worth 13,250. In this transaction Principal Financial Officer of this company bought 2,500 shares at a rate of $5.30, taking the stock ownership to the 2,500 shares. Before that another transaction happened on Aug 11 ’25, when Company’s Chief Development Officer sold 22,073 for $5.15, making the entire transaction worth $113,713. This insider now owns 221,799 shares in total.
Aldeyra Therapeutics Inc (ALDX) Latest Financial update
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.27 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.22) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 34.31% per share during the next fiscal year.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Trading Performance Indicators
Check out the current performance indicators for Aldeyra Therapeutics Inc (ALDX). In the past quarter, the stock posted a quick ratio of 2.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.72, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.31 in one year’s time.
Technical Analysis of Aldeyra Therapeutics Inc (ALDX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.96 million. That was better than the volume of 1.1 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 69.70%.
During the past 100 days, Aldeyra Therapeutics Inc’s (ALDX) raw stochastic average was set at 71.59%, which indicates a significant decrease from 88.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.46 in the past 14 days, which was higher than the 0.30 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.07, while its 200-day Moving Average is $4.49. However, in the short run, Aldeyra Therapeutics Inc’s stock first resistance to watch stands at $5.89. Second resistance stands at $6.24. The third major resistance level sits at $6.73. If the price goes on to break the first support level at $5.05, it is likely to go to the next support level at $4.55. The third support level lies at $4.20 if the price breaches the second support level.
Aldeyra Therapeutics Inc (NASDAQ: ALDX) Key Stats
There are currently 60,163K shares outstanding in the company with a market cap of 333.30 million. Presently, the company’s annual sales total 0 K according to its annual income of -55,850 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -7,690 K.
